Literature DB >> 3693116

Okilactomycin, a novel antibiotic produced by a Streptomyces species. I. Taxonomy, fermentation, isolation and characterization.

H Imai1, K Suzuki, M Morioka, Y Numasaki, S Kadota, K Nagai, T Sato, M Iwanami, T Saito.   

Abstract

Okilactomycin, a novel antibiotic, was isolated from the culture filtrate of a strain of actinomycetes. The producing organism, strain YP-02908L, was identified as Streptomyces griseoflavus subsp. zamamiensis subsp. nov. The antibiotic was extracted with ethyl acetate and purified by silica gel column chromatography. It was obtained as colorless prisms from a dichloromethane solution. It exhibited weak antimicrobial activity against Ehrlich ascites carcinoma in vivo. The apparent molecular formula of okilactomycin was determined as C24H32O6. It is a new member of the lactone group antibiotics.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3693116     DOI: 10.7164/antibiotics.40.1475

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  8 in total

1.  A concise total synthesis of (±)- and (-)-okilactomycin D.

Authors:  Dawen Niu; Thomas R Hoye
Journal:  Org Lett       Date:  2012-01-24       Impact factor: 6.005

2.  Synthesis of (-)-okilactomycin by a Prins-type fragment-assembly strategy.

Authors:  Jason M Tenenbaum; William J Morris; Daniel W Custar; Karl A Scheidt
Journal:  Angew Chem Int Ed Engl       Date:  2011-05-10       Impact factor: 15.336

3.  Pyranone natural products as inspirations for catalytic reaction discovery and development.

Authors:  Benjamin R McDonald; Karl A Scheidt
Journal:  Acc Chem Res       Date:  2015-03-06       Impact factor: 22.384

4.  Stereoselective Synthesis and Anticancer Activity of 2,6-Disubstituted trans-3-Methylidenetetrahydropyran-4-ones.

Authors:  Tomasz Bartosik; Joanna Drogosz-Stachowicz; Anna Janecka; Jacek Kędzia; Barbara Pacholczyk-Sienicka; Jacek Szymański; Katarzyna Gach-Janczak; Tomasz Janecki
Journal:  Materials (Basel)       Date:  2022-04-21       Impact factor: 3.748

5.  Evolution of the total synthesis of (-)-okilactomycin exploiting a tandem oxy-cope rearrangement/oxidation, a Petasis-Ferrier union/rearrangement, and ring-closing metathesis.

Authors:  Amos B Smith; Todd Bosanac; Kallol Basu
Journal:  J Am Chem Soc       Date:  2009-02-18       Impact factor: 15.419

Review 6.  Spirotetronate polyketides as leads in drug discovery.

Authors:  Michelle H Lacoske; Emmanuel A Theodorakis
Journal:  J Nat Prod       Date:  2014-12-01       Impact factor: 4.050

7.  Synthesis of 2,2,6-Trisubstituted 5-Methylidene-tetrahydropyran-4-ones with Anticancer Activity.

Authors:  Tomasz Bartosik; Jacek Kędzia; Joanna Drogosz-Stachowicz; Anna Janecka; Urszula Krajewska; Marek Mirowski; Tomasz Janecki
Journal:  Molecules       Date:  2020-01-30       Impact factor: 4.411

8.  Secondary Metabolites of Actinomycetales as Potent Quorum Sensing Inhibitors Targeting Gram-Positive Pathogens: In Vitro and In Silico Study.

Authors:  Said E Desouky; Mohammed Abu-Elghait; Eman A Fayed; Samy Selim; Basit Yousuf; Yasuhiro Igarashi; Basel A Abdel-Wahab; Amnah Mohammed Alsuhaibani; Kenji Sonomoto; Jiro Nakayama
Journal:  Metabolites       Date:  2022-03-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.